Liquid Biopsy & Translational Clinical Genomics
Circulating tumour DNA and serial monitoring — what blood can tell us that a biopsy often cannot.
What this centre does
Blood can tell us what a biopsy often cannot — repeatedly, non-invasively, and over time. This centre works on circulating tumour DNA and other blood-based markers for early detection, minimal residual disease, treatment monitoring and resistance.
Assays & monitoring via OnKommon
Methods
ctDNA analysis and variant-allele-fraction dynamics; MRD statistical calling; clonal-haematopoiesis discrimination; longitudinal trend modelling; clinical-utility study design.
Data inputs
Serial ctDNA draws and MRD assays (via OnKommon); matched clinical outcomes; imaging response.
Outputs
Clinical-utility evidence in Indian cohorts; monitoring protocols; publications.
Funding route
Translational grants; industry collaboration on monitoring assays.
What has to be true first
Nothing new — only disciplined data capture from services already running. The cheapest credible research start the institution has.
Themes this centre carries
Work with this centre
The research centres collaborate with funders, sponsors, hospitals and academic groups. Tell us what you are working on and the enquiry is routed to the centre lead.
Contact the research office